Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Proellex in Renal Impairment
NCT00787618Phase 2Terminated
- Sponsor
- Repros Therapeutics Inc.
- Start
- Oct 2008
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in Uterine Fibroids (UF), endometriosis, sponsored by Repros Therapeutics Inc.. Started Oct 2008; status: terminated.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)endometriosis
Beyond the preview
Go deeper on NCT00787618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00787618.